Billionaire Andreas Halvorsen's Top 15 Long-Term Stock Picks
Andreas Halvorsen is a prominent Norwegian hedge fund manager and the co-founder of Viking Global, one of the most successful equity-focused hedge funds in the world.
Day One Biopharmaceuticals Inc. (DAWN)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 5,755,577 | $72,923,161 | -27% | 0.97% |
| 2. | Braidwell LP Alex Karnal | 4,873,853 | $61,751,718 | 1.83% | |
| 3. | Estuary Capital Andrew Warford | 3,716,777 | $47,091,565 | +36% | 13.75% |
| 4. | Deerfield Management James E. Flynn | 2,596,033 | $32,891,738 | -1% | 0.62% |
| 5. | Alyeska Investment Group Anand Parekh | 2,512,187 | $31,829,409 | 0.11% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.97 | 111,387 | Large Shareholder | 12,929,322 | 2023-10-20 | Filing | |
| $10.06 | 384,400 | Large Shareholder | 12,817,935 | 2023-10-19 | Filing | |
| $10.21 | 979,667 | Large Shareholder | 12,433,535 | 2023-10-18 | Filing | |
| $13.00 | 769,230 | Large Shareholder | 11,453,868 | 2023-06-09 | Filing | |
| $15.00 | 766,667 | Large Shareholder | 766,667 | 2022-06-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.96 | 4,370 | 252,638 | 2025-02-18 | Filing | ||
| $11.96 | 4,646 | 39,602 | 2025-02-18 | Filing | ||
| $11.96 | 12,048 | 128,015 | 2025-02-18 | Filing | ||
| $13.31 | 30,000 | 1,034,015 | 2024-12-10 | Filing | ||
| $13.21 | 10,554 | 108,377 | 2024-11-18 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 12,887,467 | $163,284,208 | 0% | |
| 2. | 6,430,257 | $81,471,356 | 9.93% | |
| 3. | 6,155,837 | $77,994,455 | 0% | |
| 4. | 5,848,923 | $74,105,855 | 0% | |
| 5. | 3,882,952 | $49,197,006 | 0.01% |
News See All
10 Best Up and Coming Stocks To Buy According to Analysts
Donald Trump's victory in the recent presidential election is expected to encourage companies that have been hesitant to pursue IPOs in 2025, capitalizing on the positive market reaction and anticipated...
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Q3 2024 Earnings Call Transcript
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Q3 2024 Earnings Call Transcript October 30, 2024Day One Biopharmaceuticals, Inc. beats earnings expectations.
10 Biggest Stocks with Negative Beta to Consider
Beta is a measurement of market risk or volatility that indicates how much the price of a stock tends to fluctuate up and down compared to other stocks.
13 Best Biotech Stocks To Buy Under $20
In this article, we're going to take a look at 13 best biotech stocks to buy under $20.
12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds
In this article we present the list of 12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds.
25 Biggest Stocks with Negative Beta
Stock markets were in see-saw mode before the Fed’s September decision on rate hikes.
5 Stocks with Biggest Upside Potential According to Analysts
In this article, we will take a look at the 5 stocks with biggest upside potential according to analysts.
Hedge Fund and Insider Trading News: Ken Griffin, Cliff Asness, Ray Dalio, Sanjay Shah, Brookfield Asset Management, Savara Inc (SVRA), Day One Biopharmaceuticals, Inc. (DAWN), and More
Ken Griffin is moving Citadel’s headquarters to Miami, leaving its current home of Chicago after the billionaire decried the city’s crime rate and voiced frustrations with political leadership in ...
Billionaire Hedge Funds
